Atai Life Sciences Return on Investment 2020-2024 | ATAI

Current and historical return on investment (ROI) values for Atai Life Sciences (ATAI) over the last 10 years.
Atai Life Sciences ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $-0.11B $0.17B -49.65%
2024-06-30 $-0.11B $0.19B -45.31%
2024-03-31 $-0.12B $0.24B -45.70%
2023-12-31 $-0.13B $0.26B -48.60%
2023-09-30 $-0.13B $0.29B -49.29%
2023-06-30 $-0.14B $0.23B -52.17%
2023-03-31 $-0.14B $0.26B -49.23%
2022-12-31 $-0.14B $0.28B -45.35%
2022-09-30 $-0.15B $0.31B -43.90%
2022-06-30 $-0.15B $0.32B -38.19%
2022-03-31 $-0.17B $0.36B -40.61%
2021-12-31 $-0.14B $0.39B -37.01%
2021-09-30 $-0.18B $0.46B -60.51%
2021-06-30 $-0.15B $0.49B -85.55%
2021-03-31 $-0.10B $0.12B -174.55%
2020-12-31 $-0.10B $0.10B -424.49%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.260B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.446B 0.00
Quest Diagnostics (DGX) United States $18.204B 18.28
DaVita (DVA) United States $14.448B 18.68
Encompass Health (EHC) United States $10.001B 23.58
Chemed (CHE) United States $8.458B 25.99
Elanco Animal Health (ELAN) United States $5.947B 14.15
Option Care Health (OPCH) United States $5.262B 24.93
RadNet (RDNT) United States $4.847B 107.33
LifeStance Health (LFST) United States $3.050B 0.00
Amedisys (AMED) United States $3.030B 21.56
Addus HomeCare (ADUS) United States $2.270B 26.63
Astrana Health (ASTH) United States $2.074B 28.36
U.S Physical Therapy (USPH) United States $1.339B 35.20
Pennant (PNTG) United States $0.909B 36.76
Aveanna Healthcare Holdings (AVAH) United States $0.889B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00